1Haraoui B, Pelletier JP, Cloutier JM, et al. Synovial membrame histology and immunopathology in rheumatoid arthritis and osteoarthritis:in vivo effectis of antirheumotic drugs. Arthritis Rheum, 1991,34:153
2Banerjee S, Poole AR. Immunity to cartilage proteoglycans. J Rheumatol, 1992,33(Suppl):36
4Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum, 2000,43:1916
5Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol,2001, 12:69
6Tsuruha J, Masuko-Hongo K, Kato T, et al. Implication of cartilage inermediate layer peotein in cartilage destruction in subsets of patients with OA and RA. Arthritis Rheum, 2001, 44:838
7Sakata M, Tsuzuha Jl, Masuko-Hongo K, et al. Autoantibodies to osteopontin in patients with OA and RA. J Rheumatol, 2001,8:1492
8Guerassimor A, Zhang Y, Banerjee S, et al. Cellular immuneity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with RA but only after removal of keratan sulfate. Arthris Rheum,1998,41:1019
9Glant TT, Fulop C, Buzus, et al. Mapping of arthritogenic auto immune epitopes of cartilage aggrecans in proteoglycan-induced arthritis. Scand J Rheumatol, 1995,101(Suppl):43
10Alsalameh S, Jaha B, Kreuse A, et al. Antigenicity and accessory cell function of human articular chondrocytes. J Rheumatol, 1991,18:414
